EFFICACY OF MEXIDOL (2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE CUCCINATE) INCLUSION INTO THE INFUSION THERAPY OF ALCOHOL WITHDRAWAL SYNDROME
The effect of the domestic preparation Mexidol (reactant - 2-Ethyl-6-methyl-3- hydroxypyridine Cuccinate) in the therapy of an alcohol withdrawal syndrome has been investigated. The inclusion of Mexidol leads to higher effects of the detoxification therapy of uncomplicated alcohol withdrawal syndrome. Due to its distinct detoxification, hemodynamic and antianginal effects Mexidol in an average. therapeutic dose of 300 mg a day can be recommended for a course therapy from the first day of an alcohol withdrawal syndrome manifestation. The course administration of Mexidol in the mentioned dose in i.v. infusion solution did not cause any visual or subjectively significant side effects which testifies to its good tolerance.